Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca And British American Tobacco

Published 03/14/2019, 10:06 PM

For Immediate Release

Chicago, IL – March 15, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Rio Tinto (LON:RIO) plc (NYSE:RIO) , Smith & Nephew (LON:SN) plc (NYSE:SNN) , Endava plc (NYSE:DAVA) , AstraZeneca plc (AZN) and British American Tobacco (LON:BATS) p.l.c. (NYSE:BTI) .

Here are highlights from Thursday’s Analyst Blog:

Is Britain Headed for a “Soft Brexit”? 5 Stock Picks

On the night of Mar 13, the British House of Commons delivered another crushing defeat to prime minister Theresa May. Members of parliament voted to reject a no-deal Brexit. What’s more, a large chunk of May’s cabinet abstained from voting, leading to heightened concerns about the validity of her leadership.

Meanwhile, Britain’s chancellor Philip Hammond indicated in his Spring Statement that May would likely have to agree to a soft Brexit. This would be necessary to break the deadlock currently plaguing the British parliament. He also warned of dire economic consequences if a hard or no-deal Brexit ensues.

A soft Brexit would allow Britain to retain access to the European single market. This would protect London’s position as a global financial hub. Major multinationals would also then continue to base themselves within Britain. With a soft Brexit looking increasingly possible, it would make sense to bet on major multinationals based in Britain.

May Loses Brexit Vote, Faces Dissension

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The British House of Commons initially voted 321 to 308 to reject a no-deal Brexit. Another vote followed and lawmakers bolstered their decision by 321 to 278, widening the slim gap to 43 votes.

The government’s motion stated that Britain should exit the EU without a deal on Mar 29. It would also have the option to undertake a no-deal Brexit at any other time. Of May’s ministers, 13 abstained with one voting against the party whip.

Now, on Mar 14, Britain’s parliament will decide whether it wants to delay a Brexit beyond the original deadline of Mar 29. However, the delay will only take place if the House of Commons votes for May’s Brexit deal, a proposal which has been rejected twice.

This has caused great anger among legislators keen on a Brexit as well as those supporting its softer version. Instead, May’s defeat has given rise to the feeling that a soft Brexit, where Britain retains stronger links to the EU, is increasingly a possibility.

Hammond Supports Soft Brexit, Touts Benefits

On Wednesday, Britain’s Chancellor Philip Hammond used his Spring Statement to indicate that May should now veer toward a soft Brexit. Hammond used the Spring Statement, an update on the British economy, to provide a largely upbeat picture. At the same time, he warned that a no-deal Brexit would not only result in short-term pain but could leave the country “less prosperous in the longer term.”

In the event of a soft Brexit, goods and services would be freely traded with EU members without attracting tariffs. Exports would not be subject to border checks. Britain-based financial firms would continue to enjoy the right to sell services and operate branches in the EU. Other non-members like Norway enjoy similar freedoms and continue to have access to the European Economic Area.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Further, a soft Brexit would help to release a so-called deal dividend of around £26 billion. Additionally, this would be money saved from the bills Britain currently pays to the EU. It could result in a £20 billion increase in funding to the National Health Service (NHS), according to the British government.

Our Choices

May’s latest legislative defeat and the rebellion among her party’s ranks indicate that a tougher, hard Brexit looks increasingly unlikely. As MPs prepare to vote on delaying the inevitable, a soft Brexit would be uppermost on their minds. This would enable Britain to endure a difficult phase in its history with the least economic strife possible.

A soft Brexit would allow British multinationals to retain their global headquarters within the country. It could also save the economy from most of its blushes. This is why it makes sense to invest in British MNCs. However, picking winning stocks may prove to be difficult.

This is where our VGM Score comes in. Here V stands for Value, G for Growth and M for Momentum and the score is a weighted combination of these three scores. Such a score allows you to eliminate the negative aspects of stocks and select winners. However, it is important to keep in mind that each Style Score will carry a different weight while arriving at a VGM Score.

We have narrowed down our search to the following stocks based on a good Zacks Rank and VGM Score.

Rio Tinto plc is an international mining company, headquartered in London.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Rio Tinto has a Zacks Rank #1 (Strong Buy) and VGM Score of A. The company’s expected earnings growth for the current year is 23.8%. The Zacks Consensus Estimate for the current year has improved by 18.7% over the past 30 days.

Smith & Nephew plc is a global medical device company.

Smith & Nephew has a Zacks Rank #1 and VGM Score of B. The Zacks Consensus Estimate for the current year has improved by 0.4% over the past 30 days.

Endava plc provides information technology services.

Endava has a VGM Score of B. The company’s expected earnings growth for the current year is 32%. The Zacks Consensus Estimate for the current year has improved by 4.7 over the past 30 days. The stock has a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

AstraZeneca plc is one of the largest biopharmaceutical companies in the world, headquartered in London.

AstraZeneca has a Zacks Rank #2 (Buy) and VGM Score of B. The Zacks Consensus Estimate for the current year has improved by 5.3% over the past 30 days.

British American Tobacco p.l.c. is a manufacturer, marketer and seller of tobacco products on a global basis.

British American Tobacco has a Zacks Rank #2 and VGM Score of B. The company has expected earnings growth of 8.4% for the current year. The Zacks Consensus Estimate for the current year has improved by 2.5% over the past 30 days.

Today's Best Stocks from Zacks

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Smith & Nephew SNATS, Inc. (SNN): Free Stock Analysis Report

Rio Tinto PLC (RIO): Free Stock Analysis Report

British American Tobacco p.l.c. (BTI): Free Stock Analysis Report

Endava PLC Sponsored ADR (DAVA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.